Lyra Therapeutics, Inc. financial statements
Lyra Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 398K | EODHD |
| Net income | −USD 28.92M | EODHD |
| Cash and equivalents | USD 15.89M | EODHD |
| Total debt | USD 30.26M | EODHD |
Lyra Therapeutics, Inc. financials on 6ix · Lyra Therapeutics, Inc. on 6ix